Cover Story

  • Skilling Up

    Skilling has emerged a priority in India’s pharma sector with LSSSDC, industry associations and consultants spearheading initiatives in this direction. Yet, are all the pieces needed to plug the...

  • Strategies for making high pharmaceutical quality affordable: Part II

    Dr Ajaz S Hussain, Former Deputy Director Office of Pharmaceutical Science, US FDA, currently Founder of Insight, Advice & Solutions, US and President, National Institute...

  • Quality excellence through skill development

    SM Mudda, Chairman, Regulatory Affairs Committee, IDMA and Director - Global Strategy (Technical), Micro Labs, emphasises the need to adopt a Quality Management Systems...

  • Building pharma quality: From the top-floor to the shop-floor

    Vikas Bhadoria, Senior Partner and Vivek Arora, Associate Partner, McKinsey & Company, emphasise on the need to build a strong quality culture, which will lead...

  • Skill level directly impacts quality, which has a direct impact on human life

    Ranjit Madan, CEO, Life Science Sector Skills Development Council links skill levels in the pharmaceutical sector, quality and safety of medicines, and India's global market...

  • Regulatory compliance at the shop floor is a key gap that needs to be bridged

    Hemant Deshpande, Managing Partner, Pollux Life Science Solutions, in an interaction with Viveka Roychowdhury, elaborates on the skill gap between academia and industry and how...

  • NSF’s education courses, like the APPQM, change the way people think

    Medicines are only as good as the people making them, points out Martin Lush, Global Vice President, Pharma Biotech and Medical Devices, NSF Health Sciences....

  • Driving Innovation The NDDS Way

    The need for a multidisciplinary approach to deliver greater therapeutic results has opened new avenues for growth in the novel drug delivery systems market. In this issue,...

  • Bliss GVS Pharma: Overcoming social bias

    Bliss GVS Pharma has managed to break through the social bias against suppositories and pessaries in the Sub-Saharan African market. After years of research on...

  • Zim Laboratories: On the growth path

    Zim Laboratories' oral disintegrating strips is the latest offering of this Nagpur based company's NDDS portfolio by Usha Sharma

  • Generating value in generics

    Utkarsh Palnitkar, Partner and Head, Infrastructure, Government and Healthcare, Life Sciences, KPMG in India, gives an insight on the importance to develop NDDS by Indian...

  • IPR Building Block or Stumbling Block?

    With World Intellectual Property Day round the corner, Express Pharma explores the evolving IPR scenario in India and its impact on pharma companies

  • Patent system, only way to promote innovation?

    Yogesh Pai, Assistant Professor of Law and Co-Director of the Centre for Innovation, Intellectual Property and Competition (CIIPC) at National Law University, Delhi counters the...

  • A balancing act

    Ashish Prasad, Partner, Economic Laws Practice Delhi, analyses IPR in India, elaborates on the need to evolve an effective IPR policy to encourage innovation without...

  • Techniques to enhance IP valuations

    Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates, gives an insight on why IP systems must support innovations by creating a conducive environment to attract...

  • On the right track

    Ashwin Sapra, Partner, and Biplab Lenin, Consultant, Cyril Amarchand Mangaldas, give an insight on how adequate research and development, intellectual property protection protocols and enforcement...

  • Hedging against uncertainty in the IPR Regime: Contractual protections

    Anay Shukla, Lead, Pharma Healthcare team, Darren Punnen, Member, Pharma Healthcare team and Vidya Phanse, Intern, Nishith Desai Associates, discuss contractual strategies that companies engaged...

  • The Bt cotton saga

    Rajeev Kumar, Partner, LexOrbis provides a commentary on the facts and questions of law that are raised in the current Bt. cotton patent infringement suit...

  • Rooting out Rubella: Making it Mission Possible

    The government needs to quash fears about safety of the rubella vaccine and establish its efficacy to achieve its goal of eliminating the disease by 2020

  • The Social Way to Success

    India Pharma Inc needs to leverage the potential of social media to up its game in times to come

  • Era of Electroceuticals Coming soon?

    Electroceuticals, hailed as the next frontier in medicine, is garnering considerable interest from medical researchers and entrepreneurs on the lookout for the next class of therapies

  • All bluster and no lustre?

    With little or no financial incentives in Union Budget 2017, the pharmaceutical industry remains deprived of a cure for its ailments

  • Resurrecting Brand AP

    Visakhapatnam and Nellore to play pivotal roles in rebuilding Andhra Pradesh's reputation as a leading pharma hub By Prathiba Raju

  • A Helping Hand

    The search for a sustainable, affordable and complaint access strategy is a tough task but the gains outweigh the pains By Viveka Roychowdhury

  • Trends in 2017

    What will be the most dominant business trends in the pharmaceutical sector in the year ahead?

  • Increasing access to medicines via collaboration and digitisation

    A Vaidheesh, VP, South Asia and MD, India, GlaxoSmithKline Pharmaceuticals, in an exclusive interaction with Prathiba Raju mentions that in 2017 and beyond, the pharmaceutical...

  • Where the mind is without fear…

    TK Kanchana, Director-General, Organisation of Pharmaceutical Producers of India (OPPI) talks about the trends which are most likely to drive the industry’s fortunes and company...